Category:SVG chemistry symbols:Path text

Drawings of Structural formulas can contain letters, in general very few capital letters or only one.
It may be useful to avoid the effort of embedding SVG text when drawing simple shaped letters,
and create instead short pathes for e.g. "H", "N", "O".

See also category: SVG chemistry symbols:Embed text.

Media in category "SVG chemistry symbols:Path text"

The following 200 files are in this category, out of 4,844 total.

(previous page) (next page)

(+)-(6aR,10aS)-Δ9-Tetrahydrocannabinol (with hydrogen atoms shown).svg 620 × 337; 11 KB
(+)-(6aS,10aS)-Δ9-Tetrahydrocannabinol (with hydrogen atoms shown).svg 620 × 337; 12 KB
(+)-1,7a-Diepialexine-2D-skeletal.svg 282 × 233; 10 KB
(+)-3,8-Diepialexine-2D-skeletal.svg 282 × 233; 10 KB
(+)-alpha-hexachlorocyclohexane.svg 220 × 226; 16 KB
(+)-Daphnetoxin Struktur V0.svg 409 × 286; 13 KB
(+)-Epibatidine Structural Formulae V.1.svg 336 × 255; 9 KB
(+)-Epicatechin.svg 369 × 206; 9 KB
(+)-Gallocatechin.svg 468 × 315; 17 KB
(+)-Lycoctonine Structural Formula V2.svg 454 × 341; 70 KB
(+)-Membrenone A.svg 303 × 229; 17 KB
(+)-Membrenone B.svg 303 × 227; 17 KB
(+)-Membrenone C.svg 309 × 200; 12 KB
(+)-Menthone structure.svg 163 × 247; 13 KB
(+)-Ochotensine Structural Formula V1.svg 329 × 325; 19 KB
(+)-Pseudoephedrin.svg 207 × 141; 12 KB
(+)-Tazettine Structural Formula V1.svg 384 × 299; 28 KB
(+)-Tylophorine Structural Formula V2.svg 430 × 436; 21 KB
(-)(3S,4R)-3-(4-(4-Fluorophenyl)-4-hydroxy-piperidine-1-yl)-croman-4,7-diol.svg 160 × 62; 12 KB
(-)-Anatabine Structural Formula V1.svg 234 × 183; 8 KB
(-)-beta-chamigrene.svg 330 × 240; 8 KB
(-)-Cafestol Struktur V0.svg 305 × 213; 8 KB
(-)-Cephaeline Structural Formula V1.svg 483 × 485; 36 KB
(-)-Cephalotaxine Structural Formula V1.svg 360 × 259; 22 KB
(-)-Coreximine Structural Formula V2.svg 483 × 336; 17 KB
(-)-Cytisine.svg 620 × 485; 5 KB
(-)-Dendroxine Structural Formula V1.svg 251 × 291; 39 KB
(-)-Emetine Structural Formula V1.svg 483 × 514; 38 KB
(-)-Ephedrin.svg 207 × 141; 14 KB
(-)-Harringtonine Structural Formula V1.svg 438 × 399; 37 KB
(-)-Lycodine Structural Formula V1.svg 268 × 244; 21 KB
(-)-Membrenone A.svg 303 × 229; 15 KB
(-)-Membrenone B.svg 303 × 227; 17 KB
(-)-Menthol-v2.svg 214 × 261; 7 KB
(-)-Menthone structure.svg 163 × 247; 13 KB
(-)-Pogostol.svg 370 × 375; 10 KB
(-)-triptofordin C2.svg 680 × 725; 28 KB
(17β)-10,17-Dihydroxyestra-1,4-dien-3-one.svg 600 × 403; 4 KB
(1E,4E)-1,5-diphenylpenta-1,4-dien-3-one 200.svg 254 × 99; 3 KB
(1R,2R)-Tramadol.svg 231 × 207; 20 KB
(1R,2S)-Tramadol gespiegelt.svg 231 × 207; 22 KB
(1R,2S,4R)-(+)-endo-Borneol V.5.svg 261 × 224; 17 KB
(1S)-trans-permethrin.svg 670 × 201; 18 KB
(1S,2S)-Tramadol gespiegelt.svg 231 × 207; 20 KB
(1S,3R,5R)-6-methyl-6-azabicyclo(3.2.1)octan-3-yl 2-phenylbenzoate.svg 1,165 × 835; 21 KB
(2,4,6-Trimethylbenzoyl)diphenylphosphine oxide.svg 198 × 134; 32 KB
(2,4-dihydroxyphenyl)(phenyl)methanone 200.svg 200 × 106; 5 KB
(2-Decyloxy-3-dodecylthio-1-propyl)dihydrogenphosphate.svg 644 × 182; 31 KB
(2-Methoxyethoxy)acetic-acid-2D-structure.svg 410 × 121; 7 KB
(2E,3E)-biacetyl dioxime 200.svg 170 × 96; 8 KB
(2E,4E)-deca-2,4-dienal 200.svg 288 × 67; 5 KB
(2R,3S)-1,4-dimercaptobutane-2,3-diol 200.svg 168 × 91; 7 KB
(2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexaol 200.svg 220 × 91; 8 KB
(3-Glycidoxypropyl)trimethoxysilane-2D-structure.svg 485 × 219; 14 KB
(3R,7R,11R)-Phytan.svg 594 × 91; 6 KB
(3S)-trans-permethrin.svg 512 × 145; 7 KB
(4-chlorobenzyl)(4-chlorophenyl)sulfane 200.svg 255 × 120; 5 KB
(4-methylcyclohexyl)methanol 200.svg 178 × 75; 5 KB
(4-methylcyclohexyl)methanol.svg 512 × 203; 6 KB
(6)-Helicen.svg 585 × 301; 21 KB
(bis(trifluoroacetoxy)iodo)benzene.svg 654 × 432; 4 KB
(bromomethyl)benzene 200.svg 118 × 63; 3 KB
(chloromethoxy)ethane 200.svg 143 × 32; 5 KB
(Chloromethyl)trimethylsilane-2D-structure.svg 170 × 126; 11 KB
(Diethylamino)trimethylsilane-2D-structure.svg 300 × 204; 14 KB
(E)-1,2-diphenyldiazene 200.svg 180 × 107; 2 KB
(E)-2-Butene-2D-structure.svg 257 × 84; 6 KB
(E)-2-ethylhexyl 3-(4-methoxyphenyl)acrylate 200.svg 411 × 110; 12 KB
(E)-2-Nonenal Structural Formula V1.svg 188 × 184; 10 KB
(E)-3,5-Dimethyl-2-hexene-2D-structure.svg 344 × 135; 7 KB
(E)-3-(1H-imidazol-4-yl)acrylic acid 200.svg 190 × 91; 4 KB
(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid 200.svg 253 × 153; 11 KB
(E)-3-methylpent-2-ene 200.svg 162 × 56; 8 KB
(E)-4-methylpent-2-ene 200.svg 162 × 67; 8 KB
(E)-diisopropyl diazene-1,2-dicarboxylate 200.svg 287 × 96; 16 KB
(E)-hex-2-ene 200.svg 187 × 38; 6 KB
(E)-hex-3-ene 200.svg 187 × 38; 6 KB
(E,E)-2,4-Decadial Structural Formula V1.svg 274 × 184; 11 KB
(E,E)-2,4-decadienal.svg 633 × 63; 4 KB
(E,E,E,E)-Retinylacetat V1.svg 699 × 193; 16 KB
(peroxybis(propane-2,2-diyl))dibenzene 200.svg 230 × 107; 13 KB
(pyridin-2-ylmethylene)bis(4,1-phenylene) diacetate 200.svg 362 × 156; 11 KB
(R)- and (S)-2,3-Dimethylpentane.svg 263 × 79; 44 KB
(R)- and (S)-salbutamol.svg 512 × 422; 9 KB
(R)-(+)-Panthenol Structural Formulae V.1.svg 520 × 213; 20 KB
(R)-(−)-modafinil.svg 512 × 408; 5 KB
(R)-2-Chloro-2-fluoropentane.svg 512 × 276; 2 KB
(R)-2-Ethylhexanol Structural Formula V1.svg 343 × 150; 10 KB
(R)-2-Ethylhexanol Structural Formula V2.svg 343 × 145; 10 KB
(R)-2-Methylbutanoic acid.svg 315 × 225; 5 KB
(R)-3-methylpent-1-ene 200.svg 160 × 56; 8 KB
(R)-Acetoin.svg 620 × 428; 7 KB
(R)-Acetylcarnitine V.3.svg 395 × 319; 27 KB
(R)-Carphedon Structural Formula V1.svg 418 × 149; 11 KB
(R)-citalopram.svg 512 × 366; 3 KB
(R)-Citronellol2.svg 129 × 179; 5 KB
(R)-Ketoprofen.svg 345 × 138; 7 KB
(R)-Limonen.svg 138 × 201; 12 KB
(R)-MBDB Structural Formula V1.svg 386 × 163; 14 KB
(R)-Mesopram.svg 512 × 237; 5 KB
(R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine 200.svg 157 × 153; 3 KB
(R)-Nicotine Structural Formula V1.svg 224 × 164; 6 KB
(R)-pentan-2-ol 200.svg 162 × 67; 7 KB
(R)-Phantolid Structural Formula V1.svg 369 × 235; 20 KB
(R)-Phenylglycinol.svg 99 × 69; 5 KB
(R)-Praziquantel.svg 580 × 365; 16 KB
(R)-Sarin.svg 344 × 162; 11 KB
(R)-Scoulerine.svg 700 × 455; 19 KB
(R)-sec-butyl acetate 200.svg 187 × 67; 10 KB
(R)-Terfenadine Structural Formula V.1.svg 485 × 278; 25 KB
(R)-Tocotrienol (R3=CH3) V.1.svg 1,073 × 308; 40 KB
(R)-Tropicamid Structural Formula V1.svg 405 × 199; 12 KB
(R,R) bisphenol A diglycidyl ether 200.svg 363 × 131; 16 KB
(R,R)-Nabilone chemical structure.svg 586 × 314; 1,009 bytes
(R,R)-Pristane FormulaV1.svg 701 × 130; 21 KB
(R,S) bisphenol A diglycidyl ether 200.svg 363 × 131; 17 KB
(R,S)-ifosfamide.svg 512 × 291; 9 KB
(R,S)-Phantolid Structural Formula V1.svg 369 × 235; 18 KB
(RR)- and (SS)- fenoterol.svg 512 × 384; 14 KB
(RRR)-Tocomonoenols Structural Formulae V.1.svg 1,073 × 308; 41 KB
(RRR)-Tocomonoenols terminal Structural Formulae V.1.svg 1,073 × 308; 41 KB
(RRR)-Tocopherols Structural Formulae V.1.svg 1,073 × 308; 41 KB
(RRR)-Tocopheryl Acetate Structural Formulae V.1.svg 1,143 × 326; 46 KB
(RS)-2-Ethylhexanol Structural Formula V1.svg 343 × 118; 6 KB
(RS)-Carphedon Structural Formula V1.svg 418 × 149; 8 KB
(RS)-Gallopamil Structural Formula V.1.svg 931 × 720; 96 KB
(RS)-Ibuprofen Structural Formula V1.svg 432 × 189; 11 KB
(RS)-Ketamine-Structural Formulae V2.svg 510 × 213; 15 KB
(RS)-Methyprylon Structural Formulea V.1.svg 693 × 270; 39 KB
(RS)-Metoprolol Structural Formula V1.svg 679 × 195; 13 KB
(RS)-Octinoxat Structural Formula V1.svg 720 × 191; 13 KB
(RS)-Sarin.svg 344 × 163; 12 KB
(RS)-Terazosine Structural Formulae V.1.svg 661 × 823; 64 KB
(RS)-Tropicamid Structural Formula V1.svg 405 × 199; 10 KB
(RS,SR)-mefloquine.svg 512 × 308; 13 KB
(S)-(+)-modafinil.svg 512 × 408; 5 KB
(S)-(-)-2-Azetidinecarboxylic acid.svg 348 × 323; 3 KB
(S)-1,2,3,6-tetrahydro-2,3'-bipyridine 200.svg 135 × 107; 2 KB
(S)-2-amino-2-(3-hydroxyisoxazol-5-yl)acetic acid 200.svg 195 × 101; 7 KB
(S)-2-amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid 200.svg 220 × 134; 6 KB
(S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid 200.svg 220 × 106; 6 KB
(S)-2-aminobutanoic acid 200.svg 153 × 95; 6 KB
(S)-2-Chloro-2-fluoropentane.svg 512 × 276; 2 KB
(S)-2-Ethylhexanol Structural Formula V1.svg 343 × 154; 10 KB
(S)-2-Ethylhexanol Structural Formula V2.svg 343 × 145; 9 KB
(S)-2-Methylbutanoic acid.svg 315 × 225; 4 KB
(S)-3-acetoxy-2-aminopropanoic acid 200.svg 203 × 95; 8 KB
(S)-3-methylpent-1-ene 200.svg 160 × 56; 8 KB
(S)-4-methyl-2-(methylthio)-4-phenyl-1-(phenylamino)-1H-imidazol-5(4H)-one 200.svg 227 × 130; 10 KB
(S)-AHTN Structural formula V1.svg 394 × 220; 23 KB
(S)-Amphetamine Structural Formulae V1.svg 268 × 144; 7 KB
(S)-Carphedon Structural Formula V1.svg 418 × 149; 10 KB
(S)-Colchicine Structural Formula V1.svg 471 × 448; 22 KB
(S)-Histidinol.svg 113 × 56; 5 KB
(S)-Ketoprofen.svg 345 × 138; 7 KB
(S)-Linalyl sorbate.svg 479 × 124; 22 KB
(S)-Mesopram.svg 512 × 237; 5 KB
(S)-Methioninol.svg 133 × 48; 6 KB
(S)-myrmac aldehyde.svg 577 × 210; 8 KB
(S)-Nicotine Structural Formula V1.svg 224 × 164; 6 KB
(S)-pentan-2-ol 200.svg 162 × 67; 7 KB
(S)-Phantolid Structural Formula V1.svg 369 × 235; 19 KB
(S)-Phenylalaninol.svg 114 × 43; 5 KB
(S)-Praziquantel.svg 580 × 365; 15 KB
(S)-propranolol synthesis.svg 512 × 267; 33 KB
(S)-Sarin.svg 344 × 162; 11 KB
(S)-sec-butyl acetate 200.svg 187 × 67; 10 KB
(S)-Terfenadine Structural Formula V.1.svg 485 × 278; 26 KB
(S)-Tropicamid Structural Formula V1.svg 405 × 199; 13 KB
(S)-Tryptophanol.svg 135 × 61; 6 KB
(S,S) bisphenol A diglycidyl ether 200.svg 363 × 131; 17 KB
(S,S)-Pristane FormulaV1.svg 701 × 130; 21 KB
(S,S)-Tetrahydrochrysene.svg 1,360 × 675; 18 KB
(tetrahydrofuran-2-yl)methanol 200.svg 121 × 55; 3 KB
(Trifluoromethyl)trimethylsilane-2D-structure.svg 235 × 160; 10 KB
(Trimethylsilyl)imidazole-2D-structure.svg 218 × 235; 11 KB
(Z)-(2,3'-biindolinylidene)-2',3-dione 200.svg 194 × 134; 5 KB
(Z)-2-methylbut-2-enoic acid 200.svg 106 × 96; 8 KB
(Z)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-enone 200.svg 180 × 129; 7 KB
(Z)-3-methylpent-2-ene 200.svg 115 × 96; 8 KB
(Z)-4-methylpent-2-ene 200.svg 115 × 67; 8 KB
(Z)-but-2-enoic acid 200.svg 106 × 63; 5 KB
(Z)-hex-2-ene 200.svg 139 × 56; 6 KB
(Z)-hex-3-en-1-yl acetate 200.svg 237 × 110; 8 KB
(Z)-hex-3-ene 200.svg 162 × 81; 6 KB
(Z)-S-(2,3-dichloroallyl) diisopropylcarbamothioate 200.svg 243 × 110; 15 KB
(±)-Bornaprin Enantiomers V.1.svg 411 × 498; 34 KB
(±)-Bupranolol Structural Formulae V.1.svg 536 × 418; 53 KB
(±)-Chloroquine Enantiomers Structural Formulae V.1.svg 688 × 749; 44 KB
(±)-Climbazole Emantiomers Structural Formulae V.0a.svg 301 × 411; 23 KB
(±)-Diclofop-methyl Enantiomers Structural Formulae.svg 579 × 773; 49 KB
(±)-Dimetindene Structural Formulae.svg 4,408 × 1,960; 29 KB
(±)-Flephedrone 4-isomer Enantiomers Structural Formulae.svg 326 × 264; 21 KB
(±)-Oxoprenolol Structural Formulae V.2.svg 441 × 394; 45 KB
(±)-Primaquine Enantiomers Structural Formulae.svg 534 × 705; 9 KB
(−)-(6aR,10aR)-Δ9-Tetrahydrocannabinol (with hydrogen atoms shown).svg 620 × 337; 12 KB
(−)-(6aS,10aR)-Δ9-Tetrahydrocannabinol (with hydrogen atoms shown).svg 620 × 337; 13 KB
1 1 difluorocyclopentane.svg 512 × 452; 272 bytes
1 fluoro 1 iodocyclopropane.svg 512 × 452; 258 bytes
1,1'-azanediylbis(propan-2-ol) 200.svg 212 × 67; 9 KB

(previous page) (next page)

Retrieved from "https://commons.wikimedia.org/w/index.php?title=Category:SVG_chemistry_symbols:Path_text&oldid=278839588"